News

Scoop on UK's No to the UPC was the most-read IAM story in H1 2020

The top 20 pieces of the first six months of the year dominated by coverage of the coronavirus pandemic

Scoop on UK's No to the UPC was the most-read <em>IAM</em> story in H1 2020
A patent's journey from <em>IAM</em> Market to <em>Facebook v BlackBerry</em>
7 Jul 2020

A patent's journey from IAM Market to Facebook v BlackBerry

Analysis shows that assets listed on the platform sell at a higher rate than average, while they are also litigated more often

How a platform technology patent list can expedite covid-19 vaccine research
7 Jul 2020

How a platform technology patent list can expedite covid-19 vaccine research

More transparency around IP ownership in this vital area will help the development of treatments designed to tackle the coronavirus

Latest

View all news
5 Jul 2020

“Why I quit as Nokia IP head”; Microsoft top patent assertion target; Major German FRAND decision; ARM’s China licensee struggle; NPE targets Zoom; plus much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days Read more

4 Jul 2020

Facebook campaign highlights the power of brands, but activism is not risk-free

Consumers like companies that make stands and support causes. Authenticity is all, though; bandwagon jumpers will pay the price Read more

3 Jul 2020

Germany’s Supreme Court releases full judgment in key FRAND licensing case

Ruling in Sisvel v Haier clarifies issues around areas including what constitutes a “willing” licensee, obligations on implementers and the scope licensors have to vary royalty rates Read more

28 Jun 2020

US patent suits soar; No troll problem in Europe; China’s top IP judge wants anti-suit injunctions; Biogen loses key Tecfidera asset; The era of the mega NPE; plus much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days Read more

26 Jun 2020

The era of the mega-NPE is upon us and that wasn't part of Big Tech's plans

Fortress’s offer for Finjan means another PIPCO is set to disappear and confirms that in the IP monetisation business it is now the giants that rule the roost Read more

21 Jun 2020

Trump’s Huawei U-turn; Panasonic in huge patent deal; AbbVie wins key Humira thicket case; Time ripe for new IV, says Rivette; Nokia’s patent power; plus much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days Read more

20 Jun 2020

Japan’s position as a 5G follower will shape its IP policy

Scuttled plan to protect IoT industry from patent threats is a sign of anxiety over the landscape around the latest telecom standard Read more

17 Jun 2020

How IAM will bring together global IP leaders this September

Join us for IPBC Connect – best-in-class value creation strategies, coming to you from the people who know, throughout the month Read more

14 Jun 2020

World’s top patent firms named; Rare Google assertion targets Sonos; USPTO head troubled by filings fall; Fortress acquires Finjan; IP finance on the up; plus much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days Read more

13 Jun 2020

It’s a great time to be involved in IP finance

Why you should expect an increase in patent-focused financing deals involving biotech and other life sciences companies Read more

11 Jun 2020

We name the world's top patent lawyers, attorneys, practices and firms

The 2020 edition of the IAM Patent 1000 features in-depth analysis of the markets in 48 key jurisdictions and is based on thousands of submissions, interviews and client references Read more

7 Jun 2020

Huawei's core 5G SEP lead; InterDigital nabs Nokia IP head; MPEG LA hopeful on CRISPR pool; The 368 entities with 1,000+ US patents; TiVo CIPO departs; plus much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days Read more

6 Jun 2020

It’s time for the auto sector to speak with a more coherent voice on IP

There are numerous challenges facing OEMs, suppliers and new players which call for more coordinated action Read more

31 May 2020

IP no covid-19 vaccine barrier; Samsung’s $2.4bn annuities bill; Google, Facebook patent sprees; Chinese NPE crackdown call; EPO top for quality, USPTO slips; plus much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days Read more

30 May 2020

Politics look set to trump patents in China’s coronavirus vaccine effort

Remarks made by Xi Jinping suggest that if a Chinese company develops a covid-19 cure, compulsory licensing’s big moment might not arrive after all Read more

26 May 2020

WHO covid-19 IP pool launches this week without strong pharma support

Open and global sharing of patents, data and know-how is seen as a step too far by many life sciences innovators Read more

25 May 2020

Japanese covid-19 patent pledge triples membership, but users must read fine print

Big-name electronics and chemical companies have continued to sign on, but several have taken the opportunity to narrow the terms of the pledge and remind potential infringers that they won’t tolerate abuse Read more

24 May 2020

Aon’s big IP insurance move; Huawei, Qualcomm, Samsung back new pool; US patent sales soar; Iancu covid-19 licensing exclusive; Uber patenting secrets; plus much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days Read more

23 May 2020

The coronavirus has ended all hope of US patent eligibility reform

Opponents of stronger laws have seized the opportunity created by the pandemic to build a narrative that will make legislative changes to the 101 regime almost impossible to secure Read more

22 May 2020

Iancu on new USPTO licensing platform – “IP will play critically important role in fighting pandemic”

The agency's Patents 4 Partnerships initiative is designed to help rights owners make relevant assets available in fight against covid-19 Read more

21 May 2020

Global calls for compulsory covid-19 patent licensing build

Scrutiny of biopharma innovators’ coronavirus IP strategies will continue to intensify in coming months as concerns mount about access to treatments Read more

20 May 2020

From the archive – Japan’s patent story

A look into the IAM back catalogue to see how we have covered the developing face of IP strategy in one of the world's great innovation powers Read more

20 May 2020

IP Hall of Fame 2020 inductees announced

A UK Supreme Court justice, a former USPTO acting director, a globally-renowned IP scholar, a trailblazing trademark lawyer and a one-time presidential candidate form the class of 2020 Read more

18 May 2020

PGR decision provides much-needed clarity in fast-growing microbiome space

First post-grant decision in the technology sector nevertheless gives some hope to gut bacteria innovators, despite invalidating a key cancer treatment patent Read more

17 May 2020

Ominous covid-19 signs for IP; Acacia lands Yahoo! patents; Gamechanging German FRAND ruling; Top EPO filing firms; WiLAN’s huge IBM chip patent deal; plus much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days Read more

16 May 2020

IP is here to stay, but everything is going to change

As IAM celebrates its 100th issue, a look back at how it all began, a fast forward to the future and a massive thank-you Read more

15 May 2020

Patent owners should prepare for further PTAB changes

From key case law to radical new ways of working, four leading experts share their predictions about what might happen next at the board Read more

15 May 2020

Five key takeaways from Akebia v Fibrogen

UK High Court judgment highlights vulnerability of broad Markush claims Read more

14 May 2020

From the archive – IV through the years

A look in to the IAM back catalogue to see how we have covered the evolution of the pioneering patent market player Read more

14 May 2020

Why patent practitioners are warming to Iancu’s PTAB reforms

Leading experts put recent changes to post-issuance reviews under the microscope and like what they see Read more

13 May 2020

Ominous signs for the global IP market in a covid-19 world

Leading in-house and private practice lawyers share their experiences of working in the shadow of a pandemic and explain what they believe might happen next Read more

12 May 2020

How to win post-issuance reviews at the PTAB

Thought leaders from key US law firms debate how to maximise the chances of success in an inter partes review Read more

10 May 2020

USPTO backlog warning; Todd Dickinson RIP; Japanese giants make covid-19 patent pledge; Strong quarters for licensing leaders; NPE targets eight with former Blackberry IP; plus much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days Read more

9 May 2020

Patent dealmaking cannot escape the effects of worsening Sino-US relations

Despite the improving Chinese IP environment and trade deal commitments, long-term personal relationships are likely to be increasingly important in getting transactions over the line Read more

7 May 2020

"The entire environment has put a really big spotlight on tech transfer," says University of Kentucky licensing head

Ian McClure explains why the current covid-19 crisis could herald a revolution in the academic institutions’ licensing efforts, but also warns of potential dangers ahead Read more

View all news